ASHIBIO Trademark

Trademark Overview

On Friday, December 30, 2022, a trademark application was filed for ASHIBIO with the United States Patent and Trademark Office. The USPTO has given the ASHIBIO trademark a serial number of 97736990. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, August 8, 2025. This trademark is owned by ashibio, Inc.. The ASHIBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in preventing and treating rare bone and connective tissue diseases and disorders
ashibio

General Information

Serial Number97736990
Word MarkASHIBIO
Filing DateFriday, December 30, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, August 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in preventing and treating rare bone and connective tissue diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 4, 2023
Primary Code005
First Use Anywhere DateTuesday, March 11, 2025
First Use In Commerce DateTuesday, March 11, 2025

Trademark Owner History

Party Nameashibio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party Nameashibio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005

Trademark Events

Event DateEvent Description
Tuesday, September 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 3, 2023NEW APPLICATION ENTERED
Wednesday, January 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2023ASSIGNED TO EXAMINER
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 26, 2024SOU TEAS EXTENSION RECEIVED
Thursday, December 26, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 26, 2024SOU EXTENSION 1 GRANTED
Wednesday, June 26, 2024SOU EXTENSION 1 FILED
Wednesday, June 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 26, 2024SOU EXTENSION 2 FILED
Friday, December 27, 2024SOU EXTENSION 2 GRANTED
Thursday, May 22, 2025USE AMENDMENT FILED
Thursday, May 22, 2025TEAS STATEMENT OF USE RECEIVED
Friday, June 27, 2025TEAS PETITION TO REVIVE RECEIVED
Friday, June 27, 2025NOTICE OF REVIVAL - E-MAILED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 29, 2025ASSIGNED TO LIE
Friday, August 8, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, June 27, 2025PETITION TO REVIVE-GRANTED
Friday, June 27, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 16, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

ashibio connective tissue diseases disorders bone rare preparations preventing treating pharmaceutical